2026-04-27 · Hosted by Melissa Lee · CNBC

Intel posted its best day since 1987, closing at a record high for the first time in nearly 26 years after crushing earnings expectations. The SMH ETF surged 5% to an all-time high while the SOX extended its longest-ever winning streak to 18 days. Nvidia reclaimed the $5 trillion market cap milestone. The panel debated Intel’s valuation, with Karen Finerman noting she sold her position (bought at ~$20, sold at ~$40) and would not buy back at current levels. In other stories, Lilly’s GLP-1 pill Foundaio saw only 3,700 prescriptions in its second week versus Novo’s 18,000, giving Novo shareholders relief. Alibaba announced its Qwen AI model integration into BYD, Li Auto, and other Chinese automakers. The DOJ dropped its Powell probe, with Fed rate cuts not priced until July 2027.

The market narrative has decisively shifted from GPU-only to CPU as the dominant AI investment theme. As AI moves beyond large language model training into inferencing and agentic workloads, CPUs are becoming the constraint, not just GPUs. Intel is the primary beneficiary, but the addressable market expansion benefits the entire semiconductor supply chain, from memory to packaging to connectivity.

Lilly’s disappointing Foundaio prescription numbers relative to Novo’s comparable product are shifting the competitive narrative in the obesity drug race. With Novo trading at roughly half Lilly’s earnings multiple and both stocks down similarly in 2026, the valuation gap appears increasingly unjustified. Multiple panelists are positioning long Novo, viewing it as a fundamental value opportunity rather than merely a tactical trade.

Alibaba’s integration of its Qwen model into multiple major Chinese automakers signals the maturation of China’s AI ecosystem beyond cloud services into real-world applications. Combined with Alibaba’s massive CapEx build-out mirroring U.S. hyperscalers, this positions Chinese tech companies as serious AI infrastructure players, not just e-commerce platforms.

The intersection of AI spending and layoffs creates a complex dynamic: companies are simultaneously investing heavily in AI infrastructure while cutting headcount. Kevin Warsh’s argument that AI enhances productivity could paradoxically support both lower inflation (productivity gains) and higher unemployment (job displacement), creating tension within the Fed’s dual mandate. —-

The semiconductor rally and earnings momentum drive optimism, but the panel consistently flags that Intel’s valuation is stretched and better opportunities exist elsewhere in the chip space.

Intel valuation disconnect: $400B+ market cap on ~$7B adjusted net income; margins nowhere near historic 60%+ peaks

Analyst reluctance to upgrade: Most Wall Street analysts did not upgrade after 23% rally, signaling valuation concerns

U.S. government stake overhang: 11% position in Intel; liquidation risk if government decides to take profits

GLP-1 pill competition: Foundaio’s weak launch could intensify pricing pressure across the obesity drug market

China regulatory risk: Alibaba’s AI push still subject to Chinese government policy shifts

Mag 7 earnings risk: Four reporting on Fed Day creates concentration risk for any disappointment

Energy-driven inflation: April-May CPI increases seen as inevitable; potential emergency hike was priced weeks ago

AI spending returns: Meta’s $135B CapEx and broader tech CapEx surge raise sustainability questions

Fed independence: Only one retiring senator stood between executive branch and Fed interference

Software sector drag: Persistent weakness in software could weigh on broader tech if semis momentum fades

This episode was covered in today’s The Market Signal — 2026-04-27, a cross-source synthesis of multiple podcast reports.